UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2691-2697

2012

Volltextzugriff (PDF)

Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma

Journal der Deutschen Dermatologischen Gesellschaft, 2011-04, Vol.9 (4), p.277-286

2011

Volltextzugriff (PDF)

Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease

Journal of immunotherapy (1997), 2016-05, Vol.39 (4), p.188-190

2016

Volltextzugriff (PDF)

Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanoma

Journal of patient-reported outcomes, 2021-08, Vol.5 (1), p.78-78, Article 78

2021

Volltextzugriff (PDF)

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

Frontiers in oncology, 2021-05, Vol.11, p.672172-672172

2021

Volltextzugriff (PDF)

Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma – an update

Journal der Deutschen Dermatologischen Gesellschaft, 2020-06, Vol.18 (6), p.582-609

2020

Volltextzugriff (PDF)

Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg

International journal of cancer, 2024-07, Vol.155 (10), p.1808-1823

2024

Volltextzugriff (PDF)

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis

Cancer Immunology, Immunotherapy, 2016-08, Vol.65 (8), p.951-959

2016

Volltextzugriff (PDF)

Effective and Tolerable Treatment of Advanced Basal Cell Carcinoma With Vismodegib Despite Renal Insufficiency

JAMA dermatology (Chicago, Ill.), 2016-12, Vol.152 (12), p.1387

2016

Volltextzugriff (PDF)

Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS

Melanoma research, 2024-02, Vol.34 (1), p.44-53

2024

Volltextzugriff (PDF)

Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma

Melanoma research, 2019-04, Vol.29 (2), p.187-195

2019

Volltextzugriff (PDF)

Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology

Journal der Deutschen Dermatologischen Gesellschaft, 2009-01, Vol.7 (1), p.21-28

2009

Volltextzugriff (PDF)

Rare cutaneous side effect of vemurafenib : Fever and exanthema 14 days after therapy initiation

Hautarzt, 2021-11, Vol.72 (11), p.1014-1016

2021

Volltextzugriff (PDF)

67-year-old male with cervical lymph node swelling : Preparation for the specialist examination: part 45

Hautarzt, 2019-04, Vol.70 (Suppl 1), p.72-74

Kähler, Katharina C

2019

Volltextzugriff (PDF)

Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy

Journal der Deutschen Dermatologischen Gesellschaft, 2008-10, Vol.6 (10), p.829-837

2008

Volltextzugriff (PDF)

Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results

Onkologie, 2008-07, Vol.31 (7), p.398-403

2008

Volltextzugriff (PDF)

Individualized therapy of disseminated cancer using malignant melanoma as a model

Cancer and metastasis reviews, 2006-06, Vol.25 (2), p.253-256

2006

Volltextzugriff (PDF)

New promises in the adjuvant, and palliative treatment of melanoma

Cancer treatment and research, 2007, Vol.135, p.277

2007

Volltextzugriff (PDF)

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis

Frontiers in oncology, 2021-10, Vol.11, p.765608-765608

2021

Volltextzugriff (PDF)

Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysis

Archives of dermatology (1960), 2010-06, Vol.146 (6), p.687

2010

Volltextzugriff (PDF)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

Oncotarget, 2017-10, Vol.8 (45), p.79731-79741

2017

Volltextzugriff (PDF)

Selecting living donors for uterus transplantation: lessons learned from two transplantations resulting in menstrual functionality and another attempt, aborted after organ retrieval

Archives of gynecology and obstetrics, 2018-03, Vol.297 (3), p.675-684

2018

Volltextzugriff (PDF)

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

Oncotarget, 2017-09, Vol.8 (44), p.76029-76043

2017

Volltextzugriff (PDF)

Living-Donor Uterus Transplantation: Pre-, Intra-, and Postoperative Parameters Relevant to Surgical Success, Pregnancy, and Obstetrics with Live Births

Journal of clinical medicine, 2020-08, Vol.9 (8), p.2485

2020

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaFemale

ThemaPatients

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(22)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Oncology
(13)
Dermatology
(12)
Humans
(12)
Melanoma
(9)
Skin Neoplasms - Drug Therapy
(7)
Melanoma - Drug Therapy
(6)
Aged
(4)
Malignant Melanoma
(4)
Melanoma - Secondary
(4)
Antineoplastic Agents - Therapeutic Use
(3)
Male
(3)
Medicine
(3)
Medicine & Public Health
(3)
Medicine, Research & Experimental
(3)
Melanoma - Immunology
(3)
Research & Experimental Medicine
(3)
Skin Neoplasms - Pathology
(3)
Antibodies, Monoclonal - Adverse Effects
(2)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma

Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease

Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanoma

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma – an update

Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis

Effective and Tolerable Treatment of Advanced Basal Cell Carcinoma With Vismodegib Despite Renal Insufficiency

Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS

Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma

Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology

Rare cutaneous side effect of vemurafenib : Fever and exanthema 14 days after therapy initiation

67-year-old male with cervical lymph node swelling : Preparation for the specialist examination: part 45

Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy

Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results

Individualized therapy of disseminated cancer using malignant melanoma as a model

New promises in the adjuvant, and palliative treatment of melanoma

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis

Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysis

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

Selecting living donors for uterus transplantation: lessons learned from two transplantations resulting in menstrual functionality and another attempt, aborted after organ retrieval

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

Living-Donor Uterus Transplantation: Pre-, Intra-, and Postoperative Parameters Relevant to Surgical Success, Pregnancy, and Obstetrics with Live Births

Aktive Filter

Suchergebnisse filtern